Nardo Bruno, Caraceni Paolo, Puviani Lorenza, Pertosa Anna Maria, Domenicali Marco, Pariali Milena, Angiolini Graziella, Chieco Pasquale, Trevisani Franco, Bernardi Mauro, Cavallari Antonino
Department of Surgery, Intensive Care and Transplantation, University of Bologna, Bologna, Italy.
J Surg Res. 2006 Oct;135(2):394-401. doi: 10.1016/j.jss.2006.03.032. Epub 2006 Jun 14.
Optimization of the conditions for regeneration is a major goal in the management of patients with acute liver failure (ALF). Previous observations suggested that hyperoxygenation of the liver may improve its regenerative capacity. Thus, this study aimed to determine whether an additional supply of oxygenated blood achieved by portal vein arterialization (PVA) is protective in rat ALF caused by toxin administration or hepatectomy.
Sprague-Dawley rats were subjected or not to PVA after CCl(4) intoxication or extended hepatectomy. PVA was performed by interposing a stent between the left renal artery and splenic vein after left nephrectomy and splenectomy. Liver injury was evaluated by the serum ALT level and necrotic cell count. Hepatocyte regeneration was assessed by calculating the mitotic index and bromodeoxyuridine (BrdU) staining. The 10-day survival was assessed in separate experimental groups.
The pO(2) in portal blood increased significantly following PVA. In the CCl(4)-induced ALF, serum ALT levels and necrosis were significantly reduced in arterialized than non-arterialized rats. PVA greatly promotes liver regeneration in both models. Finally, PVA significantly improved survival compared to controls (CCl(4): 100 versus 40%; 90% hepatectomy: 90 versus 30%). Interestingly, in the CCl(4)-induced ALF, survival was 100% even when the shunt was closed after 48 h.
These data indicate that the additional supply of arterial oxygenated blood through PVA promotes a rapid regeneration leading to the resolution of toxic-induced massive liver necrosis and a faster restoration of liver mass after partial hepatectomy in rats. Thus, PVA may represent a novel tool for optimizing hepatocyte regeneration.
优化肝脏再生条件是急性肝衰竭(ALF)患者治疗的主要目标。既往观察表明,肝脏的高氧状态可能会提高其再生能力。因此,本研究旨在确定通过门静脉动脉化(PVA)额外供应氧合血对毒素给药或肝切除所致大鼠急性肝衰竭是否具有保护作用。
将Sprague-Dawley大鼠在四氯化碳中毒或扩大肝切除术后进行或不进行PVA。PVA通过在左肾切除和脾切除后在左肾动脉和脾静脉之间插入支架来完成。通过血清ALT水平和坏死细胞计数评估肝损伤。通过计算有丝分裂指数和溴脱氧尿苷(BrdU)染色评估肝细胞再生。在不同的实验组中评估10天生存率。
PVA后门静脉血中的pO₂显著升高。在四氯化碳诱导的急性肝衰竭中,动脉化大鼠的血清ALT水平和坏死程度明显低于未动脉化大鼠。PVA在两种模型中均极大地促进了肝脏再生。最后,与对照组相比,PVA显著提高了生存率(四氯化碳组:100%对40%;90%肝切除组:90%对30%)。有趣的是,在四氯化碳诱导的急性肝衰竭中,即使在48小时后关闭分流,生存率仍为100%。
这些数据表明,通过PVA额外供应动脉氧合血可促进快速再生,从而导致毒素诱导的大面积肝坏死得到缓解,并使大鼠部分肝切除术后肝脏质量更快恢复。因此,PVA可能是一种优化肝细胞再生的新工具。